Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment
Status:
Active, not recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
This study will test the effectiveness and relative efficacy of behavioral and pharmacologic
treatments, alone and in combination, for the treatment of binge eating disorder (BED) in
patients with obesity. This is an acute treatment comparing behavioral weight loss alone or
in combination with naltrexone/bupropion medication.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)